Ewings sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 19, Issue SUPPL. 2, 2008, Pages

  Paulussen, M ^a,e   Bielack, S ^b,e   Jurgens H ^c,e   Jost, L ^d,e  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b OLGAHOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d Kantonsspital ^*  (Germany)

^e ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; TOPOTECAN; VINCRISTINE;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; EWING SARCOMA; FOLLOW UP; HUMAN; LUNG METASTASIS; METASTASIS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR BIOPSY; BONE TUMOR; INCIDENCE; PATHOLOGY; PRACTICE GUIDELINE; TUMOR RECURRENCE;

BONE NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SARCOMA, EWING'S;

EID: 45149086116     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn103     Document Type: Article

References (12)

1. Bacci G, Ferrari S, Bertoni F et al. Prognostic factors in nonmetastatic Ewings sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol 2000; 18: 4-11.
2. Bernstein ML, Devidas M, Lafreniere D et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457 - a report from the Childrens Oncology Group. J Clin Oncol 2006; 24: 152-159.
3. Pinkerton CR, Bataillard A, Guillo S et al. Treatment strategies for metastatic Ewings sarcoma. Eur J Cancer 2001; 37: 1338-1344.
4. Cotterill SJ, Ahrens S, Paulussen M et al. Prognostic factors in Ewings tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewings Sarcoma Study Group. J Clin Oncol 2000; 18: 3108-3114.
5. Nesbit ME Jr, Gehan EA, Burgert EO et al. Multimodal therapy for the management of primary, nonmetastatic Ewings sarcoma of bone: A longterm follow-up of the first intergroup study. J Clin Oncol 1990; 8: 1664-1674.
6. Burgert EO Jr, Nesbit ME, Garnsey LA et al. Multimodal therapy for the management of nonpelvic, localized Ewings sarcoma of bone: Intergroup study IESS-II. J Clin Oncol 1990; 8: 1514-1524.
7. Grier HE, Krailo MD, Tarbell NJ et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewings sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348: 694-701.
8. Schuck A, Ahrens S, Paulussen M et al. Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003; 55: 168-177.
9. Bacci G, Forni C, Longhi A et al. Long-term outcome for patients with nonmetastatic Ewings sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 2004; 40: 73-83.
10. Paulussen M, Ahrens S, Craft AW. Ewings tumors with primary lung metastases. Survival analysis of 114 (European Intergroup) Cooperative Ewings Sarcoma Study patients. J Clin Oncol 1998; 16: 3044-3052.
11. Cangir A, Vietti TJ, Gehan EA et al. Ewings sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewings sarcoma studies. Cancer 1990; 66: 887-893.
12. EURO-E.W.I.N.G. 99 treatment manual. http://euro-ewing.klinikum.uni-muenster.de/ (last accessed 2007-03-14).